CDC-RFA-CK-23-0054 rev.pdf

Centers for Disease Control and Prevention

National Center for Emerging and Zoonotic Infectious Diseases

CDC-Mexico Cooperative Agreement for Surveillance, Epidemiology, and Laboratory Capacity

CDC-RFA-CK-23-0054

06/20/2023

Table of Contents A. Funding Opportunity Description

B. Award Information

C. Eligibility Information

D. Application and Submission Information

E. Review and Selection Process

F. Award Administration Information

G. Agency Contacts

H. Other Information

I. Glossary

Part I. Overview

Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Subscribe" button link to ensure they receive notifications of any changes to CDC-RFA- CK-23-0054. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry (ATSDR) B. Notice of Funding Opportunity (NOFO) Title:

CDC-Mexico Cooperative Agreement for Surveillance, Epidemiology, and Laboratory Capacity C. Announcement Type: New - Type 1:

This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf.

Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html (See section 45 CFR 46.102(d)).

D. Agency Notice of Funding Opportunity Number:

CDC-RFA-CK-23-0054

E. Assistance Listings Number:

93.283 https://www.grants.gov/ https://www.grants.gov/ https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html

F. Dates:

1. Due Date for Letter of Intent (LOI):

2. Due Date for Applications:

06/20/2023 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov.

3. Due Date for Informational Conference Call:

N/A

G. Executive Summary:

1. Summary Paragraph CDC announces a new five-year cooperative agreement (CoAg) to strengthen public health systems in Mexico and enhance binational efforts to address infectious diseases of public health importance to Mexico, the US, and the border region. The program is intended to support the recipient with developing strategies to (1) strengthen and update binational protocols and collaboration, (2) enhance public health epidemiology and laboratory capacity, (3) expand the network partnerships of the Binational Technical Working Group, and (4) improve availability of and access to binational data, surveillance and analytics. The ultimate objective of this CoAg is to improve health outcomes for evidence-based programs; and advance the capacity of public health systems in Mexico to identify, respond to, and mitigate public health threats.

a. Eligible Applicants:

Open Competition

b. Funding Instrument Type:

CA (Cooperative Agreement)

c. Approximate Number of Awards

d. Total Period of Performance Funding:

$5,000,000

e. Average One Year Award Amount:

$1,000,000

f. Total Period of Performance Length:

5 year(s)

g. Estimated Award Date:

August 31, 2023

h. Cost Sharing and / or Matching Requirements:

No Cost sharing or matching funds are not required for this program. Although no statutory matching requirement for this NOFO exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

Part II. Full Text https://www.grants.gov/

A. Funding Opportunity Description

1. Background

a. Overview The United States and Mexico share a 2,000-mile border, which has over 400 million legal northbound crossings a year through over 20 ports of entry and located in at least 7 major sister-city regions. Mexico is the second largest trading partner of the United States (after Canada and before China) and over 54 million persons of Mexican origin live in the United States.

Additionally, thousands of migrants (including regular and irregular migrants and asylum seekers) arrive from other countries and use Mexico's territory as a crossing bridge to get to crossing points within the United States-Mexico border region, and, since 1997, Mexico’s Secretariat of Health has collaborated with CDC in the development and implementation of binational infectious disease surveillance and coordination efforts. This close geographic and socioeconomic relationship between the United States and Mexico has profound public health implications for the health systems of the two countries. Numerous binational infectious disease outbreaks including vaccine-preventable, foodborne, vector-borne, mycobacteriosis and mycotic diseases have been documented over the last two decades. Optimal detection, investigation, and control for binational outbreaks and pandemic response requires binational coordination;

therefore, sustained support to the existing surveillance and communication systems between Mexican and the United States public health officials is a priority for protecting Americans against imported infectious diseases, especially within the context of the recent COVID-19 pandemic. It is in the interests of the United States and Mexico to continue the established bilateral efforts to strengthen epidemiologic networks and laboratory infrastructure and expand, the public health activities conducted and the geographic scope as relevant and feasible. Priority areas for this cooperative agreement include: 1) enhancement of surveillance for infectious diseases of binational concern; 2) enhancement of the laboratory data reporting capacity; 3) enhancement of binational outbreak response capacity; 4) evaluation of programs and systems in place and implementation of lessons learned, in the plan to develop strong bilateral response efforts to public health events of importance. The purpose of this NOFO is to establish the collaboration to work in a coordinated manner, not only with public health governmental institutions of Mexico but also with academic partners and to conduct complementary activities to reach CDC-specific Goals and Objectives related to United States-Mexico binational strategies to prevent and control infectious diseases, within the period of validity of this cooperative agreement.

b. Statutory Authorities This program is authorized under the Public Health Service Act, Sections 307 and 317(k)(1) [42 U.S.C. 242l and 247b(k)(1)], as amended.

c. Healthy People 2030 This program addresses the Health People 2030 focus topic areas of: Global Health (https://www.health.gov/healthypeople/objectives-and-data/browse-objectives/global-health), GH-D01 — Increase the number of individuals trained globally to prevent, detect, or respond to public health threats

GH-D02 — Increase the number of globally important public health events that are tracked and reported https://www.health.gov/healthypeople/objectives-and-data/browse-objectives/global-health

GH-D03 — Increase laboratory diagnostic testing capacity, surveillance, and reporting globally

IID-17 — Reduce tuberculosis cases

IID-D03 — Increase the proportion of adults age 19 years or older who get recommended vaccines

d. Other National Public Health Priorities and Strategies This NOFO supports CDC’s Global Health Strategy (http://www.cdc.gov/globalhealth/strategy/), which focuses on improving the health and well-being of people around the world, improving capabilities to prepare for and respond to infectious diseases, other emerging health threats and public health emergencies; building country public health capacity as means to achieving lasting health improvements; and maximizing the potential of CDC’s global programs to achieve public health impact.

e. Relevant Work The Division of Global Migration and Quarantine (DGMQ)-US-Mexico Unit combines binational efforts and communication systems pertaining to public health infectious disease issues relevant to U.S. and Mexico. The implementation of this effort started in previous Cooperative Agreements with U.S-Mexico fiduciary entities that have supported the collaboration between CDC and Mexico’s Ministry of Health (MOH). The work proposed aligns strategically with CDC/NCEZID global strategy.

2. CDC Project Description

a. Approach

Bold indicates period of performance outcome.

http://www.cdc.gov/globalhealth/strategy/

CDC-RFA-CK-23-0054 Logic Model: CDC-Mexico Cooperative Agreement for Surveillance, Epidemiology, and Laboratory Capacity

Bold indicates period of performance outcome

Strategies and Activities

Short-Term Outcomes Intermediate Outcomes

Long-Term Outcomes

Enhance Public Health (PH) Epidemiologic and Laboratory Capacity

- Improved accurate and timely assessment of exposures for all notifiable disease through epidemiologic and contact investigations

- Increased public health lab capacity to identify infectious disease pathogens of binational interest

- Reduced incidence of infectious diseases of binational interest

- Reduced infectious diseases health disparities among border, binational, and mobile populations

- Improved health outcomes of border, binational, and mobile populations

- Increased availability of accurate and reliable epidemiologic and laboratory data to inform public health policymakers

Enhance Surveillance Network for Detection, Prevention, and Control of Diseases among border, binational, and mobile populations

- Improved detection and response to infectious disease exposures and high-risk conditions

- Enriched binational communication and notification networks

- Increased health literacy and decreased vaccine hesitancy

- improved effective procedures for binational notification of infectious diseases

- Efficient coordination of disease surveillance networks with binational public, private, and community stakeholders

- Improved capacity to identify, report, and respond to public health needs of border, binational, and mobile populations.

Translate Program Evaluation Findings

- Augmented transparency of binational program

- Increased sharing of binational data to stakeholders to

- Expanded availability of binational PH into Actionable Interventions responsiveness and efficacy encourage regional replication and collaboration data to inform Healthy People 2030 objectives

Respond to potential public health emergencies of international concern (PHEIC)

- Enhanced timeliness in providing binational data of PHEIC

- Launched early outbreak alerts of

PHEIC

- Increased efficient responsiveness to

PHEIC

- Strengthened binational relationship with CDC to respond to PHEIC

i. Purpose Enhance public health capacity in Mexico to better prevent and respond to public health threats of binational concern (including epidemiology and laboratory), and to strengthen the surveillance and reporting system between the U.S. and Mexico. This work will be accomplished by working collaboratively with both existing governmental public health infrastructure and science/educational organizations such as local universities interested and dedicated in the development and/or enhancement of the public health care services.

ii. Outcomes

1. Enhance Public Health (PH) epidemiologic and laboratory capacity.

Improved capacity to identify, report, and respond to public health needs of border, bi-national, and mobile populations.

2. Enhance surveillance network for detection, prevention, and control of diseases among border, bi-national, and mobile populations.

Improved accurate and timely assessment of exposures for all bi-national notifiable diseases.

Enriched bi-national communication and notification networks.

3. Translate program evaluation findings into actionable interventions.

Reduced infectious disease health disparities among border, bi-national, and mobile populations.

4. Respond to potential public health emergencies of international concern (PHEIC).

iii. Strategies and Activities Strategy 1: Enhance Public Health (PH) Epidemiologic and Laboratory Capacity

1. Develop and support (already existing) enhanced epidemiologic and lab surveillance systems, with a specific focus on pathogen of bi-national interest.

2. Establish preparedness response to bi-national bioterrorism threats.

3. Provide training on bi-national laboratory reporting/response and notifiable disease identification.

4. Enhance lab capacity to test partnerships and external stakeholder partnerships to counter health misinformation.

5. Enhance vaccination communication strategies to address vaccine hesitancy.

6. Develop collaborative protocols for notification of pathogens of bi-national interest.

7. Expand data collection and programs focused on border, bi-national, and mobile populations.

Strategy 2: Enhance Surveillance Network for Bi-national Activities for Detection, Prevention, and Control of Diseases

1. Expand internal partnerships and external stakeholder partnerships to counter health misinformation.

2. Enhance vaccination communication strategies to address vaccine hesitancy.

3. Develop collaborative protocols for notification of pathogens of bi-national interest.

4. Expand data collection and programs focused on border, bi-national, and mobile populations.

Strategy 3: Translate Program Evaluation Findings into Actionable Interventions

1. Develop and implement a monitoring and evaluation (M&E) plan for priority bi-national public health threats.

2. Assess timeliness of disease reporting and start of public health action.

3. Develop and publish data for action through peer-reviewed manuscripts, publicly available reports, and publicly available databases, when appropriate.

Strategy 4: Respond to potential public health emergencies of international concern

1. Increase awareness, prevention, detection, treatment, and vaccination (when available) of pathogens that could contribute to PHEIC, outbreaks, and/or pandemics.

2. Enhance public health communication strategies for border, bi-national and migrant populations.

1. Collaborations

a. With other CDC projects and CDC-funded organizations:

The recipient may need to interact with other CDC programs to obtain local support or epidemiological data.

b. With organizations not funded by CDC:

Recipients are encouraged to establish, build, and/or maintain collaborative relationships with organizations not funded by CDC (e.g., universities, community-based organizations providing prevention services, health care providers, commercial laboratories) to support the implementation of the proposed program.

Memoranda of Agreements (MOA), Memoranda of Understanding (MOU), letters of commitment, or service agreements are required to formally document proposed and current collaborations. These documents should describe the scope of work, intensity, duration, specific activities, and which parties are responsible for each specific activity.

2. Target Populations Target populations include all persons susceptible to disease with infectious agents of public health importance, specifically border, bi-national and mobile populations in Mexico. Within these target populations, potentially vulnerable populations may include, for example, women of reproductive age, children, unaccompanied minors, people with limited health literacy as well as any population within the scope of vulnerable populations.

https://www.cdc.gov/ncbddd/disabilityandhealth/disability-inclusion.html

a. Health Disparities Overall, the strategies and activities described in this NOFO are designed to benefit and inclusive of people with disabilities; tribal populations; mobile populations; non-Spanish speaking populations; people with limited health literacy. For all these populations the strategies and https://www.cdc.gov/ncbddd/disabilityandhealth/disability-inclusion.html activities in this NOFO will help prevent human illness and death from infectious diseases and food and/or water poisoning. One of the main goals of this NOFO is to prevent infectious diseases to travel across the borders along with the thousands of people who live on one side of the border and cross it every day to go to work, school or business. Early detection of infectious diseases outbreaks and a bi-national communication system between border health offices will ultimately improve human health among all populations including disadvantaged populations living in both sides of the border and immigrant populations.

iv. Funding Strategy N/A

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy

Strategy 1: Enhance Public Health (PH) Epidemiologic and Laboratory Capacity

1. Surveillance system with improved tracking, reporting, and information sharing for drug resistant and other pathogens of binational public health importance.

2. Training workshops for bioterrorism threat identification.

3. Revised and updated list of notifiable diseases.

4. Designed and launched projects of bi-national interest to evaluate, prevent, and control outbreaks through laboratory and epidemiologic investigations.

Strategy 2: Enhance Surveillance Network for Bi-national Activities for Detection, Prevention, and Control of Diseases

1. Established protocols for sharing critical data and information between MOH and USG stakeholders

2. Implemented projects to address vaccine hesitant border, bi-national, and mobile populations.

3. Supported online initiatives focused on tracking bi-national infectious disease prevalence and incidence

4. Improved surveillance systems to monitor the health of mobile populations.

Strategy 3: Translate Program Evaluation Findings into Actionable Interventions

1. Established working relationships with health centers, academia, community organizations, media, etc., to disseminate science-based information.

2. Timely manuscripts and reports describing results of public health programs with succinct recommendations and/or description of initiatives using data developed in real-time.

Strategy 4: Respond to potential public health emergencies of international concern (PHEIC)

1. Timely communication of potential bi-national cases of PHEIC.

2. Efficient response initiatives in the border region of pathogens that could develop to

PHEIC.

ii. Applicant Evaluation and Performance Measurement Plan

Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How the applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant)

Plans for updating the Data Management Plan (DMP) as new pertinent information becomes available. If applicable, throughout the lifecycle of the project. Updates to DMP should be provided in annual progress reports. The DMP should provide a description of the data that will be produced using these NOFO funds; access to data;

data standards ensuring released data have documentation describing methods of collection, what the data represent, and data limitations; and archival and long-term data preservation plans. For more information about CDC’s policy on the DMP, see https://www.cdc.gov/grants/additional-requirements/ar-25.html.

Where the applicant chooses to, or is expected to, take on specific evaluation studies, the applicant should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, if applicable, within the first 6 months of award, as described in the Reporting Section of this NOFO.

c. Organizational Capacity of Recipients to Implement the Approach The applicant should describe operational work capacity in Mexico and access to governments, health ministries, agricultural ministries and animal health agencies in Mexico.

The applicant should describe experience managing U.S. federal funds.

The applicant should describe their organizational structure, including identifying qualified personnel with expertise in public health projects, epidemiology and laboratory activities addressing diseases of local and international impact.

The applicant should describe program planning skills to implement disease surveillance and surveillance training development with the ministry of health; workforce development and training; development of public health capacity for outbreak response and disease control of governmental institutions, the ability to identify and work with academic institutions whose work https://www.cdc.gov/grants/additional-requirements/ar-25.html focuses on public health, and the ability to aid in the development or enhancement of public health laboratory capacity.

d. Work Plan

Period of Performance Outcome:

[from Outcomes section and/or logic model]

Outcome Measure:

[from Evaluation and Performance Measurement section]

Strategies and Activities Process Measure

[from Evaluation and Performance Measurement section]

Responsible Position / Party

Completion Date

1.

2.

3.

4.

5.

6.

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and recipients, site visits, and recipient reporting (including work plans, performance, and financial reporting).

Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking recipient progress in achieving the desired outcomes.

Ensuring the adequacy of recipient systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities deemed necessary to monitor the award:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that recipients are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with recipients on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk recipients.

1. The recipient will be required to establish, build, and maintain relationships with the CDC Project Officer and with the specific responsible office or branch at CDC for all projects proposed to address strategies and activities described in this NOFO.

2. Collaboration will include consultation for the development of plans and budgets for specific proposed projects, in order to ensure that projects meet the overall objectives of this NOFO and are consistent with and meet CDC program-specific objectives and available resources. Collaboration will additionally include development of evaluation measures for tracking performance of each specific proposed project.

3. The recipient will be required to collaborate with CDC monitor and evaluate the scientific and operational accomplishments of individual projects, as well as the overall progress in achieving the purpose of the program.

f. CDC Program Support to Recipients

Program has substantial involvement to support recipient in the implementation of activities, execution of federal funds.

1. Provides in-country administrative support to assure CoAg execution meets U.S.

Government financial and reporting requirements, and that activities also meet the compliance requirements issued by the Office of Management and Budget (OMB).

2. Provide technical oversight for all activities under this award.

3. Provide training on subjects related with the activities listed in the work plan.

4. Support emergency interventions conducted by subject-matter experts.

5. Provide intervention and planning support and assistance for recipient personnel through short and long-term exchanges of experts.

6. Provide personnel and/or resources available to help recipient overcome unexpected challenges during a project execution.

7. Maintain open communication with recipient and is committed to inform any administration change within the U.S. Government that may impact directly the execution of the CoAg activities.

8. Provide technical assistance in support of planning, implementation and evaluation of disease surveillance and intervention activities as well as training activities.

9. Provide assistance with developing program activities, data management and analysis, quality assurance, the presentation and possibly publication of program results and findings.

10. Advise and assist in the provision of special reagents or other materials and laboratory supplies as needed.

11. Facilitates sharing of publications, lessons learned, and best practices with recipient through conference calls, webinars or table-top meetings.

12. Promotes data and/or information exchange between Ministries of Health in the Latin- American region.

13. Shares with recipient data, information and publications pertinent to the work plan produced by CDC and HHS, to ensure that new activities are not being duplicated.

14. Provides consultation and scientific and technical assistance based on appropriate

HHS/CDC.

15. Facilitates bi-national reporting of urgently notifiable diseases.

16. Provide documents to promote the use of best practices known at the time.

17. Promotes bi-national surveillance and laboratory data sharing between U.S. and Mexico epidemiologic intelligence systems.

B. Award Information

1. Funding Instrument Type:

CA (Cooperative Agreement) CDC's substantial involvement in this program appears in the CDC Program Support to Recipients Section.

2. Award Mechanism:

U51

3. Fiscal Year:

4. Approximate Total Fiscal Year Funding:

$1,000,000

5. Total Period of Performance Funding:

$5,000,000 This amount is subject to the availability of funds.

Estimated Total Funding:

$5,000,000

6. Total Period of Performance Length:

5 year(s) year(s)

7. Expected Number of Awards:

8. Approximate Average Award:

$1,000,000 Per Budget Period

9. Award Ceiling:

$0 Per Budget Period

This amount is subject to the availability of funds.

10. Award Floor:

$0 Per Budget Period

11. Estimated Award Date:

August 31, 2023

12. Budget Period Length:

12 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total period of performance comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

13. Direct Assistance Direct Assistance (DA) is not available through this NOFO.

If you are successful and receive a Notice of Award, in accepting the award, you agree that the award and any activities thereunder are subject to all provisions of 45 CFR part 75, currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.

C. Eligibility Information

1. Eligible Applicants

Eligibility Category:

00 (State governments)

01 (County governments)

02 (City or township governments)

04 (Special district governments)

05 (Independent school districts)

06 (Public and State controlled institutions of higher education)

07 (Native American tribal governments (Federally recognized))

08 (Public housing authorities/Indian housing authorities)

11 (Native American tribal organizations (other than Federally recognized tribal governments))

12 (Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education)

13 (Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education)

20 (Private institutions of higher education)

23 (Small businesses)

25 (Others (see text field entitled "Additional Information on Eligibility" for clarification))

99 (Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility")

Additional Eligibility Category:

Government Organizations:

State governments or their bona fide agents (includes the District of Columbia)

Local governments or their bona fide agents

Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau

State controlled institutions of higher education

American Indian or Alaska Native tribal governments (federally recognized or state-recognized)

Non-government Organizations

American Indian or Alaska native tribally designated organizations

Other

Ministries of Health

2. Additional Information on Eligibility

N/A

3. Justification for Less than Maximum Competition

4. Cost Sharing or Matching

Cost Sharing / Matching Requirement:

No Cost sharing or matching funds are not required for this program. Although no statutory matching requirement for this NOFO exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

5. Maintenance of Effort

N/A

D. Application and Submission Information

1. Required Registrations

An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

PLEASE NOTE: Effective April 4, 2022, applicants must have a Unique Entity Identifier (UEI) at the time of application submission (SF-424, field 8c). The UEI is generated as part of SAM.gov registration. Current SAM.gov registrants have already been assigned their UEI and can view it in SAM.gov and Grants.gov. Additional information is available on the GSA website, SAM.gov, and Grants.gov- Finding the UEI.

a. Unique Entity Identifier (UEI):

All applicant organizations must obtain a Unique Entity Identifier (UEI) number by registering in SAM.gov prior to submitting an application. A UEI number is a unique twelve-digit identification number assigned to the registering organization.

If funds are awarded to an applicant organization that includes sub-recipients, those sub-recipients must provide their UEI numbers before accepting any funds.

b. System for Award Management (SAM):

The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as a recipient. All applicant organizations must register with SAM, and will be assigned a SAM number and a Unique Entity Identifier (UEI). All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC.

If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process can require 10 or more business days, and registration must be renewed annually. Additional information about registration procedures may be found at SAM.gov and the SAM.gov Knowledge Base.

c. Grants.gov:

The first step in submitting an application online is registering your organization at www.grants.gov, the official HHS E-grant Web site. Registration information is located at the "Applicant Registration" option at www.grants.gov.

All applicant organizations must register at www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants should start the registration process as early as possible.

Step System Requirements Duration Follow Up https://www.grants.gov/ https://www.gsa.gov/about-us/organization/federal-acquisition-service/office-of-systems-management/integrated-award-environment-iae/iae-systems-information-kit/unique-entity-identifier-update https://sam.gov/content/home https://grantsgovprod.wordpress.com/2021/09/14/how-to-find-an-applicants-uei-within-grants-gov/ https://grantsgovprod.wordpress.com/2021/09/14/how-to-find-an-applicants-uei-within-grants-gov/ https://sam.gov/content/home https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.fsd.gov%2Fgsafsd_sp%3Fid%3Dgsa_kb_view2%26kb_id%3Df66d8e6cdb76d4100d73f81d0f9619c6&data=04%7C01%7Ccshifflett%40dminc.com%7C8eee7a2adab549a3b3c008d925e9a364%7Cdb7ac9ef779d46e59bca00509580ad6b%7C0%7C0%7C637582507851821018%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=UrR%2B%2FM2wWF2fZG05Z8O6JS2C3FXXSl%2F7B3%2FB45XHRrg%3D&reserved=0 https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.fsd.gov%2Fgsafsd_sp%3Fid%3Dgsa_kb_view2%26kb_id%3Df66d8e6cdb76d4100d73f81d0f9619c6&data=04%7C01%7Ccshifflett%40dminc.com%7C8eee7a2adab549a3b3c008d925e9a364%7Cdb7ac9ef779d46e59bca00509580ad6b%7C0%7C0%7C637582507851821018%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=UrR%2B%2FM2wWF2fZG05Z8O6JS2C3FXXSl%2F7B3%2FB45XHRrg%3D&reserved=0 https://grants.gov/ https://www.grants.gov/ http://www.grants.gov/

System for Award Management

(SAM)

1. Go to SAM.gov and designate an E-Biz POC (You will need to have an active SAM account before you can register on grants.gov). The UEI is generated as part of your registration.

3-5 Business Days but up to 2 weeks and must be renewed once a year

For SAM Customer Service Contact https://fsd.gov/ fsd-gov/ home.do Calls:

866-606-8220

2 Grants.gov

1. Set up an individual account in Grants.gov using organization's new UEI number to become an Authorized Organization Representative (AOR)

2. Once the account is set up the E-BIZ POC will be notified via email

3. Log into grants.gov using the password the E-BIZ POC received and create new password

4. This authorizes the AOR to submit applications on behalf of the organization

It takes one day (after you enter the EBiz POC name and EBiz POC email in SAM) to receive a UEI (SAM) which will allow you to register with Grants.gov and apply for federal funding.

Register early!

Applicants can register within minutes.

2. Request Application Package

Applicants may access the application package at www.grants.gov.

3. Application Package

Applicants must download the SF-424, Application for Federal Assistance, package associated with this notice of funding opportunity at www.grants.gov.

4. Submission Dates and Times

If the application is not submitted by the deadline published in the NOFO, it will not be processed. Office of Grants Services (OGS) personnel will notify the applicant that their application did not meet the deadline. The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant is authorized to submit a paper application, it must be received by the deadline provided by OGS.

a. Letter of Intent Deadline (must be emailed)

b. Application Deadline

Due Date for Applications 06/20/2023

06/20/2023 https://sam.gov/content/home https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do

11:59 pm U.S. Eastern Time, at www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which Grants.gov operations resume.

Due Date for Information Conference Call N/A

5. Pre-Award Assessments

Risk Assessment Questionnaire Requirement

CDC is required to conduct pre-award risk assessments to determine the risk an applicant poses to meeting federal programmatic and administrative requirements by taking into account issues such as financial instability, insufficient management systems, non-compliance with award conditions, the charging of unallowable costs, and inexperience. The risk assessment will include an evaluation of the applicant’s CDC Risk Questionnaire, located at https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, as well as a review of the applicant’s history in all available systems; including OMB-designated repositories of government-wide eligibility and financial integrity systems (see 45 CFR 75.205(a)), and other sources of historical information. These systems include, but are not limited to: FAPIIS (https://www.fapiis.gov/), including past performance on federal contracts as per Duncan Hunter National Defense Authorization Act of 2009; Do Not Pay list; and System for Award Management (SAM) exclusions.

CDC requires all applicants to complete the Risk Questionnaire, OMB Control Number 0920- 1132 annually. This questionnaire, which is located at https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, along with supporting documentation must be submitted with your application by the closing date of the Notice of Funding Opportunity Announcement. If your organization has completed CDC’s Risk Questionnaire within the past 12 months of the closing date of this NOFO, then you must submit a copy of that questionnaire, or submit a letter signed by the authorized organization representative to include the original submission date, organization’s EIN and UEI.

When uploading supporting documentation for the Risk Questionnaire into this application package, clearly label the documents for easy identification of the type of documentation. For example, a copy of Procurement policy submitted in response to the questionnaire may be labeled using the following format: Risk Questionnaire Supporting Documents _ Procurement Policy.

Duplication of Efforts

Applicants are responsible for reporting if this application will result in programmatic, budgetary, or commitment overlap with another application or award (i.e. grant, cooperative agreement, or contract) submitted to another funding source in the same fiscal year.

Programmatic overlap occurs when (1) substantially the same project is proposed in more than one application or is submitted to two or more funding sources for review and funding consideration or (2) a specific objective and the project design for accomplishing the objective are the same or closely related in two or more applications or awards, regardless of the funding source. Budgetary overlap occurs when duplicate or equivalent budgetary items (e.g., https://www.grants.gov/ https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf equipment, salaries) are requested in an application but already are provided by another source.

Commitment overlap occurs when an individual’s time commitment exceeds 100 percent, whether or not salary support is requested in the application. Overlap, whether programmatic, budgetary, or commitment of an individual’s effort greater than 100 percent, is not permitted.

Any overlap will be resolved by the CDC with the applicant and the PD/PI prior to award.

Report Submission: The applicant must upload the report in Grants.gov under “Other Attachment Forms.” The document should be labeled: "Report on Programmatic, Budgetary, and Commitment Overlap.”

6. Content and Form of Application Submission

Applicants are required to include all of the following documents with their application package at www.grants.gov.

7. Letter of Intent

LOI is not requested or required as part of the application for this NOFO.

8. Table of Contents

(There is no page limit. The table of contents is not included in the project narrative page limit.):

The applicant must provide, as a separate attachment, the “Table of Contents” for the entire submission package.

Provide a detailed table of contents for the entire submission package that includes all of the documents in the application and headings in the "Project Narrative" section. Name the file "Table of Contents" and upload it as a PDF file under "Other Attachment Forms" at www.grants.gov.

9. Project Abstract Summary

A project abstract is included on the mandatory documents list and must be submitted at www.grants.gov. The project abstract must be a self-contained, brief summary of the proposed project including the purpose and outcomes. This summary must not include any proprietary or confidential information. Applicants must enter the summary in the "Project Abstract Summary" text box at www.grants.gov.

10. Project Narrative

(Unless specified in the "H. Other Information" section, maximum of 20 pages, single spaced, 12 point font, 1-inch margins, number all pages. This includes the work plan. Content beyond the specified page number will not be reviewed.)

Applicants must submit a Project Narrative with the application forms. Applicants must name this file “Project Narrative” and upload it at www.grants.gov. The Project Narrative must include all of the following headings (including subheadings): Background, Approach, Applicant Evaluation and Performance Measurement Plan, Organizational Capacity of Applicants to Implement the Approach, and Work Plan. The Project Narrative must be succinct, self-explanatory, and in the order outlined in this section. It must address outcomes and activities to https://www.grants.gov/ https://www.grants.gov/ https://www.grants.gov/ be conducted over the entire period of performance as identified in the CDC Project Description section. Applicants should use the federal plain language guidelines and Clear Communication Index to respond to this Notice of Funding Opportunity. Note that recipients should also use these tools when creating public communication materials supported by this NOFO. Failure to follow the guidance and format may negatively impact scoring of the application.

a. Background

Applicants must provide a description of relevant background information that includes the context of the problem (See CDC Background).

b. Approach

i. Purpose

Applicants must describe in 2-3 sentences specifically how their application will address the public health problem as described in the CDC Background section.

ii. Outcomes

Applicants must clearly identify the outcomes they expect to achieve by the end of the project period, as identified in the logic model in the Approach section of the CDC Project Description.

Outcomes are the results that the program intends to achieve and usually indicate the intended direction of change (e.g., increase, decrease).

iii. Strategies and Activities

Applicants must provide a clear and concise description of the strategies and activities they will use to achieve the period of performance outcomes. Applicants must select existing evidence-based strategies that meet their needs, or describe in the Applicant Evaluation and Performance Measurement Plan how these strategies will be evaluated over the course of the project period.

See the Strategies and Activities section of the CDC Project Description.

1. Collaborations

Applicants must describe how they will collaborate with programs and organizations either internal or external to CDC. Applicants must address the Collaboration requirements as described in the CDC Project Description.

2. Target Populations and Health Disparities Applicants must describe the specific target population(s) in their jurisdiction and explain how such a target will achieve the goals of the award and/or alleviate health disparities. The applicants must also address how they will include specific populations that can benefit from the program that is described in the Approach section. Applicants must address the Target Populations and Health Disparities requirements as described in the CDC Project Description.

c. Applicant Evaluation and Performance Measurement Plan

Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement. The Paperwork Reduction Act of 1995 (PRA): Applicants are advised that any activities involving information collections (e.g., surveys, questionnaires, applications, audits, data requests, reporting, recordkeeping and disclosure requirements) from 10 or more individuals or non-Federal entities, including State and local governmental agencies, and funded or sponsored by the Federal Government are subject to review and approval by the Office of Management and Budget. For further information about CDC’s requirements under PRA see http://www.hhs.gov/ ocio/policy/collection/.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, data management plan (DMP), and other relevant data information (e.g., performance measures proposed by the applicant).

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan (including the DMP elements) within the first 6 months of award, as described in the Reporting Section of this NOFO.

d. Organizational Capacity of Applicants to Implement the Approach

Applicants must address the organizational capacity requirements as described in the CDC Project Description.

11. Work Plan

(Included in the Project Narrative’s page limit)

Applicants must prepare a work plan consistent with the CDC Project Description Work Plan section. The work plan integrates and delineates more specifically how the recipient plans to carry out achieving the period of performance outcomes, strategies and activities, evaluation and performance measurement.

12. Budget Narrative http://www.hhs.gov/ocio/policy/collection/

Applicants must submit an itemized budget narrative. When developing the budget narrative, applicants must consider whether the proposed budget is reasonable and consistent with the purpose, outcomes, and program strategy outlined in the project narrative. The budget must include:

Salaries and wages

Fringe benefits

Consultant costs

Equipment

Supplies

Travel

Other categories

Contractual costs

Total Direct costs

Total Indirect costs

Indirect costs could include the cost of collecting, managing, sharing and preserving data.

Indirect costs on grants awarded to foreign organizations and foreign public entities and performed fully outside of the territorial limits of the U.S. may be paid to support the costs of compliance with federal requirements at a fixed rate of eight percent of MTDC exclusive of tuition and related fees, direct expenditures for equipment, and subawards in excess of $25,000.

Negotiated indirect costs may be paid to the American University, Beirut, and the World Health Organization.

If applicable and consistent with the cited statutory authority for this announcement, applicant entities may use funds for activities as they relate to the intent of this NOFO to meet national standards or seek health department accreditation through the Public Health Accreditation Board (see: http://www.phaboard.org). Applicant entities to whom this provision applies include state, local, territorial governments (including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau), or their bona fide agents, political subdivisions of states (in consultation with states), federally recognized or state-recognized American Indian or Alaska Native tribal governments, and American Indian or Alaska Native tribally designated organizations. Activities include those that enable a public health organization to deliver public health services such as activities that ensure a capable and qualified workforce, up-to-date information systems, and the capability to assess and respond to public health needs. Use of these funds must focus on achieving a minimum of one national standard that supports the intent of the NOFO. Proposed activities must be included in the budget narrative and must indicate which standards will be addressed.

Vital records data, including births and deaths, are used to inform public health program and policy decisions. If applicable and consistent with the cited statutory authority for this NOFO, http://www.phaboard.org/ applicant entities are encouraged to collaborate with and support their jurisdiction’s vital records office (VRO) to improve vital records data timeliness, quality and access, and to advance public health goals. Recipients may, for example, use funds to support efforts to build VRO capacity through partnerships; provide technical and/or financial assistance to improve vital records timeliness, quality or access; or support vital records improvement efforts, as approved by CDC.

Applicants must name this file “Budget…